PTC Therapeutics Provides Updates on Translarna™ Regulatory …
https://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-provides-updates-translarnatm-regulatory
SOUTH PLAINFIELD, N.J., Dec. 5, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today an update on Translarna™ (ataluren) regulatory activities in Europe and the United States. As planned, PTC has submitted the briefing document as part of the re-examination of the initial Committee for Medicinal Products for Human Use ... japan
japan
DA: 74 PA: 74 MOZ Rank: 14